CHD
Price
$112.03
Change
+$2.87 (+2.63%)
Updated
Nov 4 closing price
Capitalization
26.57B
85 days until earnings call
Intraday BUY SELL Signals
CLX
Price
$99.16
Change
+$5.36 (+5.71%)
Updated
Nov 4 closing price
Capitalization
11.99B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CHD vs CLX

CHD vs CLX Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
Sep 27, 2026

Which Stock Would AI Choose? Church & Dwight (CHD) vs. Clorox (CLX) Stock Comparison

Key Takeaways

  • Church & Dwight (CHD) is gaining market share on volume-led organic sales growth, while Clorox (CLX) is working through an ERP (enterprise resource planning) transition that is temporarily distorting its results.
  • CHD trades at a premium valuation with modest dividend yield, whereas CLX screens as a cheaper, higher-yielding stock with a steeper recent drawdown.
  • Relative performance has diverged sharply: CHD is positive year to date, while CLX has underperformed the broader consumer staples sector.
  • Both companies face inflation, tariff, and promotional-cost pressures, but their near-term catalysts and momentum profiles point in different directions.

Introduction

Church & Dwight and Clorox are two well-known names in the household and personal care products industry, but they occupy meaningfully different positions in the current market. This stock comparison is useful for investors and traders evaluating how two consumer staples businesses with distinct growth profiles, valuation multiples, and risk factors stack up against one another. While both operate in defensive categories such as cleaning, laundry, and health products, their recent momentum, market positioning, and sentiment have diverged. The analysis below reviews each company's business context, recent relative performance, and the factors currently shaping investor expectations.

CHD Overview and Recent Performance

CHD, or Church & Dwight Co., Inc., is the leading U.S. producer of baking soda and owns brands including Arm & Hammer, OxiClean, TheraBreath, Hero, Batiste, and Touchland. The company derives roughly 80% of its sales from the U.S. and has been reshaping its portfolio by exiting slower-growing businesses, such as its vitamin brands, while acquiring faster-growing assets including hand-sanitizer maker Touchland and stain-removal brand Miss Mouth's Messy Eater.

In recent market activity, CHD has shown resilience but has not been immune to selling pressure. The stock delivered positive year-to-date gains, supported by strong quarterly results that featured organic sales growth well above management's initial guidance, driven by volume. However, in recent weeks the shares pulled back from their highs amid a broader pause in momentum. Analysts have cited a premium valuation—roughly 26 times forward earnings—as a key consideration, even as the company's gross margin expansion and 30th consecutive annual dividend increase underscore its financial discipline.

CLX Overview and Recent Performance

CLX, or The Clorox Company, manufactures cleaning, disinfecting, food, and personal care products under brands such as Clorox, Pine-Sol, Glad, Fresh Step, Hidden Valley, Brita, and Burt's Bees. The company recently completed the final phase of its U.S. ERP (enterprise resource planning) system rollout and closed its acquisition of GOJO Industries, owner of the Purell hand-sanitizer brand.

Clorox's recent stock behavior has been notably weak. The shares have fallen sharply over recent months and trade below their 50-day and 200-day moving averages. Much of the decline reflects transitory factors: retailers drew down inventory that had been built up ahead of the ERP transition, weighing on reported sales and earnings, and the company issued a voluntary product recall during the period. The stock now offers a dividend yield near 6%, reflecting both a higher payout and a lower share price. Analysts hold a predominantly "Hold" consensus rating as the market weighs these short-term disruptions against the company's longer-term transformation efforts.

Trending AI Robots

Tickeron's Trending AI Robots page is a curated showcase of the platform's most relevant automated trading strategies for current market conditions. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, but only those bots whose performance, strategy, and statistics align best with today's environment earn a place in this featured section. These bots vary widely in trading style, strategy, timeframe, performance metrics, and the sets of tickers they follow—ranging from short-term swing strategies to longer-horizon trend-following approaches. This diversity allows traders and investors to screen for automation that matches their own risk tolerance and outlook. Explore the Trending AI Robots to see which strategies are currently standing out.

Head-to-Head Comparison

The two companies diverge most clearly on growth trajectory and valuation. CHD is oriented around volume-led organic growth, premiumization, and disciplined acquisitions in faster-moving categories such as oral care and acne treatment. Its shares command a higher earnings multiple—reflecting that growth expectation—but pay a comparatively small dividend. CLX, by contrast, is a more mature, cash-generative business whose near-term results are distorted by the ERP transition and inventory drawdown. It trades at a lower earnings multiple and carries a much higher dividend yield, though the elevated payout has at times absorbed nearly all of its free cash flow.

Risk profiles also differ. CLX faces balance-sheet leverage and tighter dividend coverage following its GOJO acquisition, along with concentrated exposure to categories showing soft demand. CHD's main risks center on premium valuation, rising marketing costs, and competitive pressure from private-label brands. In terms of market sentiment, CHD has held up better despite a recent pullback, while CLX's technical posture remains bearish relative to the staples sector.

Tickeron AI Verdict

Based on observable factors, Tickeron's AI would currently lean toward CHD. The company's relative strength lies in more consistent trend behavior, volume-led organic growth, expanding margins, and a steadier earnings trajectory. CLX, while inexpensive on a valuation basis and offering a compelling dividend yield, is contending with transitory operational disruptions, weaker relative momentum, and higher balance-sheet risk. This assessment is probabilistic rather than definitive: it reflects current momentum, stability, and positioning, and could shift as Clorox's ERP-related headwinds fade and its GOJO integration matures.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
CHD vs. CLX commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHD is a Buy and CLX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CHD with price predictions
Nov 04, 2026

CHD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CHD turned positive on October 05, 2026. Looking at past instances where CHD's MACD turned positive, the stock continued to rise in 28 of 50 cases over the following month. The odds of a continued upward trend are 56%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on CHD as a result. In 46 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.

CHD moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CHD crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 38%.

Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHD advanced for three days, in 166 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.

The Aroon Indicator entered an Uptrend today. In 88 of 217 cases where CHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 41%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.

CHD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 16 (best 1 - 100 worst), indicating outstanding price growth. CHD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.112) is normal, around the industry mean (21.072). P/E Ratio (35.792) is within average values for comparable stocks, (16.552). Projected Growth (PEG Ratio) (2.688) is also within normal values, averaging (1.518). Dividend Yield (0.011) settles around the average of (0.033) among similar stocks. P/S Ratio (3.676) is also within normal values, averaging (1.902).

A.I.Advisor
a Summary for CLX with price predictions
Nov 04, 2026

CLX in +10.30% Uptrend, growing for three consecutive days on November 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CLX advanced for three days, in 179 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CLX as a result. In 43 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 44%.

The Moving Average Convergence Divergence (MACD) for CLX just turned positive on October 05, 2026. Looking at past instances where CLX's MACD turned positive, the stock continued to rise in 22 of 47 cases over the following month. The odds of a continued upward trend are 47%.

CLX moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CLX crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 54%.

The Aroon Indicator entered an Uptrend today. In 75 of 193 cases where CLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 39%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

CLX broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. CLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLX's P/B Ratio (133.239) is slightly higher than the industry average of (21.072). P/E Ratio (20.573) is within average values for comparable stocks, (16.552). Projected Growth (PEG Ratio) (1.019) is also within normal values, averaging (1.518). Dividend Yield (0.050) settles around the average of (0.033) among similar stocks. P/S Ratio (1.542) is also within normal values, averaging (1.902).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

FUNDAMENTALS RATINGS
CHD vs CLX: Fundamental Ratings
CHD
CLX
OUTLOOK RATING
1..100
4446
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
42100
SMR RATING
1..100
5210
PRICE GROWTH RATING
1..100
1646
P/E GROWTH RATING
1..100
1831
SEASONALITY SCORE
1..100
504

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHD's Valuation (85) in the Household Or Personal Care industry is in the same range as CLX (97). This means that CHD’s stock grew similarly to CLX’s over the last 12 months.

CHD's Profit vs Risk Rating (42) in the Household Or Personal Care industry is somewhat better than the same rating for CLX (100). This means that CHD’s stock grew somewhat faster than CLX’s over the last 12 months.

CLX's SMR Rating (10) in the Household Or Personal Care industry is somewhat better than the same rating for CHD (52). This means that CLX’s stock grew somewhat faster than CHD’s over the last 12 months.

CHD's Price Growth Rating (16) in the Household Or Personal Care industry is in the same range as CLX (46). This means that CHD’s stock grew similarly to CLX’s over the last 12 months.

CHD's P/E Growth Rating (18) in the Household Or Personal Care industry is in the same range as CLX (31). This means that CHD’s stock grew similarly to CLX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHDCLX
RSI
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
54%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
62%
Momentum
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
44%
MACD
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
47%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
45%
Advances
ODDS (%)
Bullish Trend 4 days ago
49%
Bullish Trend 1 day ago
56%
Declines
ODDS (%)
Bearish Trend 9 days ago
48%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
56%
Aroon
ODDS (%)
Bullish Trend 1 day ago
41%
Bullish Trend 1 day ago
39%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (CHD: $112.03 vs. CLX: $99.16)
Brand notoriety: CHD and CLX are both not notable
Both companies represent the Household/Personal Care industry
Current volume relative to the 65-day Moving Average: CHD: 120% vs. CLX: 144%
Market capitalization -- CHD: $26.57B vs. CLX: $11.99B
CHD [@Household/Personal Care] is valued at $26.57B. CLX’s [@Household/Personal Care] market capitalization is $11.99B. The market cap for tickers in the [@Household/Personal Care] industry ranges from $60.48K to $388.63B. The average market capitalization across the [@Household/Personal Care] industry is $24.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHD’s FA Score shows that 2 FA rating(s) are green while CLX’s FA Score has 2 green FA rating(s).

  • CHD’s FA Score: 2 green, 3 red.
  • CLX’s FA Score: 2 green, 3 red.
According to our system of comparison, CHD is a better buy in the long-term than CLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHD’s TA Score shows that 6 TA indicator(s) are bullish while CLX’s TA Score has 6 bullish TA indicator(s).

  • CHD’s TA Score: 6 bullish, 4 bearish.
  • CLX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CLX is a better buy in the short-term than CHD.

Price Growth

CHD (@Household/Personal Care) experienced а +6.95% price change this week, while CLX (@Household/Personal Care) price change was +14.19% for the same time period.

The average weekly price growth across all stocks in the @Household/Personal Care industry was +4.44%. For the same industry, the average monthly price growth was +5.18%, and the average quarterly price growth was +13.59%.

Reported Earning Dates

CHD is expected to report earnings on Jan 29, 2027.

CLX is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Household/Personal Care (+4.44% weekly)

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

CHD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHD has been closely correlated with CL. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CHD jumps, then CL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHD
1D Price
Change %
CHD100%
+2.63%
CL - CHD
70%
Closely correlated
+3.28%
PG - CHD
66%
Loosely correlated
+3.25%
CLX - CHD
56%
Loosely correlated
+5.71%
KMB - CHD
50%
Loosely correlated
+4.15%
KVUE - CHD
37%
Loosely correlated
N/A
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
COMP.X20.5317750.578941
+2.90%
Compound cryptocurrency
DTEC51.820.90
+1.77%
ALPS Disruptive Technologies ETF (DTEC)
ZIL.X0.0018170.000031
+1.73%
Zilliqa cryptocurrency
JANW39.840.25
+0.63%
AllianzIM U.S. Equity Buffer20 Jan ETF (JANW)
XLII24.01-0.08
-0.33%
State Street Industrial Select Sector SPDR Premium Income ETF (XLII)